FDA Approves Asahi Kasei Therapeutics’ Hovilpri (Pritelivir) for Refractory Herpes Simplex Virus in Immunocompromised Adults
WASHINGTON, D.C. — In a landmark regulatory milestone for infectious disease management, the US Food…
Tag: therapeutics
AI-Powered Oncology Specialist Iambic Therapeutics Targets $135m Nasdaq IPO Amid Bumper Year for Biotech
NEW YORK — Iambic Therapeutics, an oncology-focused biotechnology company backed by high-profile venture capital and…
CRISPR Pioneer Caribou Biosciences Winds Down Pipeline Amid Seismic Shift Toward In Vivo CAR-T Therapeutics
By Global Biotechnology Desk Published: October 2026 Despite sharing its intellectual heritage with a Nobel…
Eli Lilly Deepens Investment in Hard-to-Drug Therapeutics with Expanded Up-to-$870m Gate Bioscience Partnership
INDIANAPOLIS & SOUTH SAN FRANCISCO — Pharmaceutical giant Eli Lilly and Company is doubling down…
AstraZeneca and Daiichi Sankyo Forge Strategic Alliance with Summit Therapeutics to Evaluate Novel Combination Therapies in Solid Tumors
GLOBAL PHARMACEUTICAL LANDSCAPE — In a landmark oncology collaboration that signals a profound shift in…
